Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,008
Closed -$204K 122
2020
Q4
$204K Hold
1,008
0.04% 117
2020
Q3
$212K Sell
1,008
-100
-9% -$22.3K 0.05% 107
2020
Q2
$243K Sell
1,108
-225
-17% -$45K 0.06% 106
2020
Q1
$231K Hold
1,333
0.06% 101
2019
Q4
$205K Hold
1,333
0.04% 115
2019
Q3
$202K Hold
1,333
0.05% 107
2019
Q2
$204K Hold
1,333
0.05% 113
2019
Q1
$214K Hold
1,333
0.05% 106
2018
Q4
$205K Hold
1,333
0.06% 104
2018
Q3
$200K Sell
1,333
-200
-13% -$28.4K 0.05% 109
2018
Q2
$207K Hold
1,533
0.06% 109
2018
Q1
$204K Hold
1,533
0.06% 112
2017
Q4
$228K Buy
+1,533
New +$209K 0.06% 110
2017
Q3
Sell
-1,508
Closed -$201K 119
2017
Q2
$201K Hold
1,508
0.06% 112
2017
Q1
$203K Buy
+1,508
New +$195K 0.06% 108
2016
Q4
Sell
-1,808
Closed -$226K 109
2016
Q3
$226K Buy
+1,808
New +$237K 0.08% 104

Other funds holding CLX

Baxter Bros Inc's CLX Position: Q1 2021 in Review

Baxter Bros Inc sold out of Clorox (CLX) in Q1 2021, closing a stake of 1,008 shares — an estimated $204K sold.

Baxter Bros Inc first reported a position in CLX in Q3 2016 and held it in 16 quarters. The position peaked at $243K in Q2 2020. 1,207 funds tracked by Wall St. Rank hold CLX as of Q1 2021.

  • Baxter Bros Inc reported no remaining Clorox position as of Q1 2021 after selling out during the quarter.
  • Baxter Bros Inc sold 1,008 Clorox shares in Q1 2021, an estimated $204K.
  • Baxter Bros Inc first reported a position in Clorox in Q3 2016 and held it in 16 quarters.
  • Baxter Bros Inc's Clorox position peaked at $243K in Q2 2020.
  • 1,207 funds tracked by Wall St. Rank held Clorox as of Q1 2021.

Based on Baxter Bros Inc's 13F filing for Q1 2021, filed 23 Apr 2021.